We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA expedites regulatory reviews of breakthrough devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. Read More
Apple’s electrocardiograph (ECG) software for over-the-counter use, available as an app, has received a risk downgrade from the FDA to class II (special controls) as opposed to the highest-risk class III category. Read More
The FDA has failed to send Congress a required commitment letter for reauthorization of the Medical Device User Fee Act (MDUFA) by the Jan. 15 deadline. Read More
The agency is working with Endologix to identify patients who may benefit from treatment with the AFX2 device, updating labeling and gathering long-term safety data. Read More
French consumer electronics company Withings, a manufacturer of health status detection devices, is expanding its platform with the acquisition of Paris-based Impeto Medical, including Sudoscan, a technology for detecting peripheral neuropathy. Read More